Clinical Trials Logo

Cancer Neck clinical trials

View clinical trials related to Cancer Neck.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05979883 Recruiting - Cancer Head Neck Clinical Trials

Randomized Evaluation of Machine Learning Assisted Radiation Treatment Planning vs Standard Radiation Treatment Planning

Start date: August 7, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the magnitude of clinical benefit achieved through machine learning assisted radiation treatment planning (MLAP) on post-treatment clinical outcomes such as acute toxicity and patient reported outcomes.

NCT ID: NCT03759431 Recruiting - Larynx Cancer Clinical Trials

Vocal-cord vs. Complete Laryngeal Radiotherapy for Early Glottic Cancer

VOCAL
Start date: October 11, 2018
Phase: Phase 2
Study type: Interventional

This is a multicentrer, randomized Bayesian Phase II trial for patients with early stage (T1N0) glottic squamous cell carcinoma treated with radical radiotherapy. The primary objective is to assess the non-inferiority of local control achieved with vocal-cord only radiotherapy (VC-RT) compared to complete larynx radiotherapy (CL-RT) in T1N0 glottic laryngeal squamous cell cancer, measured at 2-years after treatment. Secondary outcomes include overall survival, as well as voice impairment, dysphagia and quality of life, measured respectively by the voice handicap index -10 (VHI-10), the MD Anderson Dysphagia Inventory (MDADI) and the MD Anderson Symptom Inventory- Head and Neck module (MDASI-HN). Patients will be randomized in a 1:3 ratio to CL-RT (39 patients) and VC-RT (116 patients) arms. There will be stratification by tumor stage (T1a/T1b) and by institution. An interim analysis is planned after the first 55 patients enrolled on the experimental arm have a 6-month follow-up.